27/08/2023
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
Nội dung bài viết
21:34 26/06/2023 Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-rando...
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer.
Oncotarget. 2016 Mar 15; 7(11): 12089–12101.
Published online 2016 Feb 25. doi: 10.18632/oncotarget.7725
PMCID: PMC4914271
PMID: 26933811
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer.
Oncotarget. 2016 Mar 15; 7(11): 12089–12101.
Published online 2016 Feb 25. doi: 10.18632/oncotarget.7725
PMCID: PMC4914271
PMID: 26933811
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study
Guang-hui Pan, Zheng Chen, Lu Xu, Jing-hui Zhu, Peng Xiang, Jun-jie Ma, Yan-wen Peng, Guang-hui Li, Xiao-yong Chen, Jia-li Fang, Yu-he Guo, Lei Zhang, and Long-shan Liu
